title: Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.
abstract: The results of recent clinical trials for the management of limited-stage Hodgkin lymphoma have led to considerable debate, especially regarding the role of radiation therapy. This review highlights those recent trials and provides perspectives regarding their interpretation from a radiation oncologist and a hematologist. The trial protocol is available at http://www.nejm.org/doi/suppl/10.1056/NEJMoa1111961/suppl_file/nejmoa1111961_protocol.pdf.
authors: National Cancer Institute of Canada (NCIC) Clinical Trials Group, Queen's University, Kingston, Ontario, Canada.
authors: Ralph M
authors: RM
authors: Meyer
authors: Richard T
authors: RT
authors: Hoppe
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D009367:Neoplasm Staging; D011878:Radiotherapy / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome